Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Herman

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Contact Dermatitis|August 7, 2019
Allergic contact dermatitis caused by isobornyl acrylate in the Enlite glucose sensor and the Paradigm MiniMed Quick-set insulin infusion setAnne Herman, Marie Baeck, Laurence de Montjoye, et al.
Contact Dermatitis|February 19, 2019
N,N-dimethylacrylamide-A new sensitizer in the FreeStyle Libre glucose sensorMartin Mowitz, Anne Herman, Marie Baeck, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 3, 2025
T helper and IL-20 cytokine signatures distinguish atopic dermatitis from contact dermatitis subtypesAxel De Greef, Léna Puigdevall, Laurence de Montjoye, et al.
Allergy|November 15, 2019
Atopic Dermatitis Score 7 (ADS7): A promising tool for daily clinical assessment of atopic dermatitisAnne-Sophie Darrigade, Caroline Colmant, Laurence de Montjoye, et al.
Contact Dermatitis|September 29, 2018
Increased expression of interleukin-9 in patients with allergic contact dermatitis caused by p-phenylenediamineMarie Baeck, Anne Herman, Laurence de Montjoye, et al.
Allergy|April 22, 2019
Increased expression of IL-24 in chronic spontaneous urticariaLaurence de Montjoye, Anne Herman, Emilie Hendrickx, et al.
Contact Dermatitis|June 6, 2019
Unexpected positive patch test reactions to sesquiterpene lactones in patients sensitized to the glucose sensor FreeStyle LibreAnne Herman, Martin Mowitz, Olivier Aerts, et al.
Contact Dermatitis|April 26, 2019
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs: Two case reports and a review of the literatureAlison Coster, Olivier Aerts, Anne Herman, et al.
JAMA Dermatology|June 26, 2020
Evaluation of Chilblains as a Manifestation of the COVID-19 PandemicAnne Herman, Caroline Peeters, Alexia Verroken, et al.
European Journal of Dermatology : EJD|September 6, 2022
Chilblains observed during the COVID-19 pandemic cannot be distinguished from classic, cold-related chilblainsAxel De Greef, Mathilde Choteau, Anne Herman, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Contact Dermatitis|August 7, 2019
Allergic contact dermatitis caused by isobornyl acrylate in the Enlite glucose sensor and the Paradigm MiniMed Quick-set insulin infusion setAnne Herman, Marie Baeck, Laurence de Montjoye, et al.
Contact Dermatitis|February 19, 2019
N,N-dimethylacrylamide-A new sensitizer in the FreeStyle Libre glucose sensorMartin Mowitz, Anne Herman, Marie Baeck, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 3, 2025
T helper and IL-20 cytokine signatures distinguish atopic dermatitis from contact dermatitis subtypesAxel De Greef, Léna Puigdevall, Laurence de Montjoye, et al.
Allergy|November 15, 2019
Atopic Dermatitis Score 7 (ADS7): A promising tool for daily clinical assessment of atopic dermatitisAnne-Sophie Darrigade, Caroline Colmant, Laurence de Montjoye, et al.
Contact Dermatitis|September 29, 2018
Increased expression of interleukin-9 in patients with allergic contact dermatitis caused by p-phenylenediamineMarie Baeck, Anne Herman, Laurence de Montjoye, et al.
Allergy|April 22, 2019
Increased expression of IL-24 in chronic spontaneous urticariaLaurence de Montjoye, Anne Herman, Emilie Hendrickx, et al.
Contact Dermatitis|June 6, 2019
Unexpected positive patch test reactions to sesquiterpene lactones in patients sensitized to the glucose sensor FreeStyle LibreAnne Herman, Martin Mowitz, Olivier Aerts, et al.
Contact Dermatitis|April 26, 2019
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs: Two case reports and a review of the literatureAlison Coster, Olivier Aerts, Anne Herman, et al.
JAMA Dermatology|June 26, 2020
Evaluation of Chilblains as a Manifestation of the COVID-19 PandemicAnne Herman, Caroline Peeters, Alexia Verroken, et al.
European Journal of Dermatology : EJD|September 6, 2022
Chilblains observed during the COVID-19 pandemic cannot be distinguished from classic, cold-related chilblainsAxel De Greef, Mathilde Choteau, Anne Herman, et al.
Pageof 5